XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Aug. 31, 2023
Aug. 31, 2022
Cash flows from operating activities:    
Net income $ 54,862 $ 71,361
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization of property and equipment 4,690 3,682
Amortization of acquired intangibles and other 71,121 52,545
Amortization of debt discount and issuance costs on Notes 1,621 1,595
Stock-based compensation 30,111 26,110
Non-cash lease expense 6,958 5,919
Gain on sale of assets held for sale 0 (10,770)
Deferred income taxes (18,521) (286)
Credit losses and other sales allowances 472 710
Changes in operating assets and liabilities:    
Accounts receivable 31,478 2,858
Other assets 14,294 11,174
Inventories 2,209 (1,264)
Accounts payable and accrued liabilities (14,027) (10,055)
Lease liabilities (7,860) (6,481)
Income taxes payable 2,362 (748)
Deferred revenue, net (39,011) 5,673
Net cash flows from operating activities 140,759 152,023
Cash flows (used in) from investing activities:    
Purchases of investments (15,262) 0
Sales and maturities of investments 15,700 1,200
Purchases of property and equipment (3,181) (3,086)
Payments for acquisitions, net of cash acquired (355,250) 0
Proceeds from sale of long-lived assets, net 0 25,998
Other investing activities 0 134
Net cash flows (used in) from investing activities (357,993) 24,246
Cash flows from (used in) financing activities:    
Proceeds from stock-based compensation plans 20,373 10,384
Payments for taxes related to net share settlements of equity awards (8,101) (5,405)
Repurchases of common stock (30,000) (75,524)
Dividend payments to stockholders (23,669) (23,351)
Proceeds from the issuance of debt 195,000 7,474
Repayment of revolving line of credit (55,000) 0
Principal payment on term loan (5,157) (5,154)
Payment of debt issuance costs 0 (1,957)
Net cash flows from (used in) financing activities 93,446 (93,533)
Effect of exchange rate changes on cash and cash equivalents 5,510 (14,027)
Net (decrease) increase in cash and cash equivalents (118,278) 68,709
Cash and cash equivalents, beginning of period 256,277 155,406
Cash and cash equivalents, end of period 137,999 224,115
Supplemental disclosure:    
Cash paid for income taxes, net of refunds of $924 in 2023 and $920 in 2022 14,640 8,954
Cash paid for interest 17,630 5,470
Non-cash investing and financing activities:    
Total fair value of restricted stock awards, restricted stock units and deferred stock units on date vested 23,077 18,204
Dividends declared and unpaid $ 8,354 $ 8,099